Skip to main content
. Author manuscript; available in PMC: 2016 Aug 14.
Published in final edited form as: ACS Infect Dis. 2015 Jun 17;1(8):380–387. doi: 10.1021/acsinfecdis.5b00053

Table 1.

Retest of Hit Compounds from Bioactive Library

compound % inhibition in screen CC50 (μM) IC50 (μM) SI (CC50/IC50)
1 lanatoside C 100.0 0.177 0.255 0.694
2 gambogic amide 100.0 0.454 1.01 0.45
3 strophanthidin 100.0 0.491 1.161 0.423
4 acetyl isogambogic acid 99.0 2.885 2.935 0.983
5 puromycin hydrochloride 99.7 3.594 0.889 4.043
6 emetine 98.3 >50 1.474 >33.921
7 plumbagin 98.3 0.756 0.919 0.823
8 cycloheximide 97.9 >50 0.608 >82.237
9 digitoxin 92.5 0.031 0.05 0.62
10 crinamine 91.5 >50 3.789 >13.196
11 mycophenolic acid 90.5 >50 0.316 >158.228
12 cantharidin 87.3 >50 11.325 >4.415
13 azacitidine 76.9 >50 4.011 >12.466
14 gedunin 72.9 5.484 0.803 6.829
15 fluorouracil 70.6 >50 >50
16 methotrexate 67.1 >50 >50
17 gemfobrozil 62.1 >50 >50
18 dramamine 57.8 >50 >50
19 vidarabine 56.1 >50 >50